Janux Therapeutics (JANX) Stock Price, Quote, News & History | Benzinga

Janux Therapeutics Inc (JANX) Stock Price, Quote, News & History

JANXNASDAQ

Trade with Public

Trade with Public

$17.39

0.110.64%

At close: Aug 21, 5:00 PM EST

$17.45

0.060.35%

After Hours: Aug 21, 4:30 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$17.40

Close

$17.39

Volume / Avg.

520.04K / 985.44K

Day Range

$17.21 - $17.70

52 Wk Range

12.12 - 35.34

Market Cap

$1.07B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

12.4%

Days to Cover

7.74

Recent Janux Therapeutics, Inc. News

Janux Therapeutics Halts Early Stage Cancer Program In 'Prudent' Move

Janux Therapeutics halts JANX008 after Phase 1a review, shifting focus to higher-priority programs despite limited but durable responses.

Vandana Singh

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

Janux Therapeutics signs a global licensing deal with Bristol Myers Squibb worth up to $800 million.

Vandana Singh

Gold Down Over 1%; Signet Shares Fall After Q3 Results

Avi Kapoor

Janux Therapeutics Stock Hits 52-Week Low After Trial Update

JANX stock hit 52-week low after releasing Phase 1 data for JANX007 in mCRPC. Encouraging efficacy and safety profile observed in trials.

Vandana Singh

Nasdaq Surges 200 Points; United Natural Foods Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-41.25M

Investing Cash Flow (TTM)

7.35M

Financing Cash Flow (TTM)

9.22M

Free Cash Flow (TTM)

-41.93M

Capital Expenditure (TTM)

-674.00K

Net Change in Cash (TTM)

-24.68M

Analyst Trends and Forecast

2

Feb

1

1

1

Apr

3

May

1

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$113.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

44.99

PB Ratio (TTM)

1.14

Earnings Yield % (TTM)

-9.49%

Earnings Yield % (FWD)

-9.77%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$15.18

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$27.77M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$17.40

Close

$17.39

Volume / Avg.

520.04K / 985.44K

Day Range

$17.21 - $17.70

52 Wk Range

12.12 - 35.34

Market Cap

$1.07B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

65

Short Interest

12.4%

Days to Cover

7.74

About

Sector

Health Care

Industry

Biotechnology

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Janux Therapeutics (JANX) stock?

A

You can purchase shares of Janux Therapeutics (NASDAQ:JANX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Janux Therapeutics (JANX) competitors?

A

Other companies in Janux Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Janux Therapeutics (JANX) stock?

A

Janux Therapeutics has a consensus price target of $48.74.

Q

What is the current price for Janux Therapeutics (JANX)?

A

The stock price for Janux Therapeutics (NASDAQ: JANX) is $17.45 last updated August 21, 2026 at 4:30 PM EDT.

Q

Does Janux Therapeutics (JANX) pay a dividend?

A

There are no upcoming dividends for Janux Therapeutics.

Q

When is Janux Therapeutics (NASDAQ:JANX) reporting earnings?

A

Janux Therapeutics does not have any upcoming earnings scheduled.

Q

Is Janux Therapeutics (JANX) going to split?

A

There is no upcoming split for Janux Therapeutics.

Q

What sector and industry does Janux Therapeutics (JANX) operate in?

A

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.